Clinical Trial Update: A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a novel combined therapy for refractory Vernal Keratoconjunctivitis has completed. The study was conducted by Zhongshan Opht…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vernal Keratoconjunctivitis

Snippet

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University | Conditions: Vernal Keratoconjunctivitis | Phase 4 | Status: COMPLETED